Tenax Therapeutics, Inc. (TENX): Shareholders' Equity
$97.07M
As of 2025-12-31
$113.59M
As of 2026-06-30
n/m
3-year compound annual growth
+83.8%
5-year compound annual growth
+4.9%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $97.07M | +5.5% | 2026-03-10, Balance as of period end |
| 2024-12-31 | $91.99M | n/m | 2026-03-10, Balance as of period end |
| 2023-12-31 | $8.10M | +442.5% | 2025-03-25, Balance as of period end |
| 2022-12-31 | $1.49M | -64.8% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $4.24M | -8.2% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $4.63M | +22.6% | 2022-03-29, Balance as of period end |
| 2019-12-31 | $3.77M | -68.0% | 2021-04-16, Balance as of period end |
| 2018-12-31 | $11.77M | +32.5% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $8.88M | -48.2% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $17.14M | -71.6% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $60.42M | n/a | 2017-03-16, Balance as of period end |
| 2015-04-30 | $70.43M | -15.0% | 2017-03-16, Balance as of period end |
| 2014-04-30 | $82.86M | n/m | 2017-03-16, Balance as of period end |
| 2013-04-30 | -$1.78M | n/m | 2014-07-29, Balance as of period end |
| 2012-04-30 | -$346.0K | n/m | 2013-06-26, Balance as of period end |
| 2011-04-30 | -$3.72M | n/a | 2012-07-25, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Tenax Therapeutics, Inc. (TENX) | 2025-12-31 | $97.07M | +5.5% |
| Abbott Laboratories (ABT) | 2025-12-31 | $52.13B | +9.4% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $18.47B | +13.1% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $26.88M | -1.8% |
| Eli Lilly & Co (LLY) | 2025-12-31 | $26.54B | +85.9% |
| Pfizer Inc (PFE) | 2025-12-31 | $86.78B | -1.9% |
| Johnson & Johnson (JNJ) | 2025-12-28 | $81.54B | +14.1% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $161.55M | +0.3% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $52.66B | +13.6% |
Compare TENX, ABT, BMY, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗